2Thrainsdottir I S, Aspelund T,Thorgeirsson G, et al. The association between glucose abnormalities and heart failure in the population based reykjavik study [ J ]. Diabetes Care, 2005,28(3) :612-616.
3Iribarren C, Karter A J, Go A S, et al. Glycemic control and heart failure among adult patients with diabetes[ J ]. Circulation, 2001,103 ( 22 ) : 2668-2673.
4Liao D, ShoferJ B, Boyko E J, et al. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese Americans with normal fastingglucose [J]. Diabetes Care,2001,24( 1 ) :39-44.
5Chiu H C,Kovacs A, Blanton R M. Transgenic expression of fatty acid transport protein 1 in the heart causeslipo toxic cardiomyopathy[ J ]. Cire Res ,2005,96 ( 2 ) :225-233.
6Golfman L S,Wilson C R,Sharma S,et al. Activation of PPAR gamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats [ J ]. Am J Physiol Endocrinol Metab, 2005,289 ( 2 ) : E328- E336.
7Opden Buijs J, Miklos Z,van Riel N A, et al. Beta adrenergic activation reveals impaired cardiac cal ciumhandling at early stage of diabetes[ J]. Life Sci ,2005,76(10) : 1083-1098.
8Belike D, Swanson E A, Dillmann W H. Decreased sarcoplasmic reticulum activiity and contractility in diabetic db/db mouse heart [ J ]. Diabetes, 2004,53 ( 12 ) : 3201-3208.
9Jweied E E, McKinney R D, Walker L A, et al. Depressed cardiac myofilament function in human diabet esmellitus [J]. Am J Physiol Heart Cire Physiol, 2005,289 ( 6 ) : H2478-H2483.
10Montanari D, Yin H, Dobrzynski E, et al. Kallikreingenedeli very im proves serum glucose and lipid profiles and cardiac function in strep to zotocin induced diabetic rats[J]. Diabetes, 2005,54 ( 5 ) : 1573 -1580.
5Golfman LS, Wilson CR, Sharma S, etal. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats [ J ]. Am J Physiol Endocrinol Metab, 2005,289(2 ) : E328-E336.
6OP den Buijs J,Miklos Z, van Riel NA, etal. Beta-adrenergic activation reveals impaired cardiac calcium handling at early stage of diabetes [J]. Life Sci,2005,76(10) :1083-1098.
8Jweied EE, McKinney RD, Walker LA, etal. Depressed cardiac myofilament function in human diabetes mellitus[J]. Am J Physiol Heart Cire Physiol, 2005,289( 6 ) : H2478- H2483.
9Montanari D, Yin H, Dobrzynski E, et al. Kallikrein gene delivery improves serum glueose and lipid profiles and eardiac function in streptozotocin-induced diabetic rats[J]. Diabetes,2005,54(5) : 1573-1580.
10Malhotra A,Begley R, Kang BP, et al. PKC-ε dependent survival signals in diabetic heart[J]. Am J Physiol Heart Circ Physiol,2005,289 (4) : H1343-H1350.
9Austin R C, Lentz S R, Werstuck G H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease [ J ]. Cell Death Differ, 2004,11 ( Suppl 1 ) :S56-S64.
10I Wood D. Established and emerging cardiovascular risk factors [ J ]. Am Heart J, 2001,141 (2 Suppl) : $49-$57.
